HPS Pharmacies wish to give notice that Link Medical has annoucned the discontinuation of Nardil® as follows:
This discontinuation is due to closure of the manufacturing site for Nardil® tablets. Link Medical has unfortunately been unable to secure adequate alternative options to cover the anticipated requirements for phenelzine tablets. Link Medical advises that patients should discuss alternative treatment options with their doctor as soon as possible.
Retain this notice in a prominent position, including in other related business for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Link Medical on 1800 181 060 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates